LABLYTICA

At Lablytica, we offer bioanalytical services to quantify your drug or biomarker in a variety of biological matrices. All method development, validation, and analysis activities at Lablytica utilize fully qualified instruments at our facility in Uppsala, Sweden. Lablytica is fully compliant with OECD GLP and performs method validation and PK sample analysis for preclinical and clinical studies according to ICH M10... Lablytica specializes in bioanalytical services, including sample analysis in plasma, tissue samples, and urine. Research and development activities carried out at our facility in Uppsala, Sweden, are fully compliant with Good Laboratory Practice (GLP) and conform to regulatory guidelines from ICH M10. The laboratory is part of the Swedish OECD GLP regulatory inspection program from SWEDAC... Since 2016, Lablytica has been part of the SWEDAC GLP inspection program for the performance of GLP analytical study phases. In November 2019, we became an independent company owned..

Registration numbers: 559217-9088 (W)

Primary location: Uppsala Sweden